SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Manuel Arias, David N. Rush, Chris Wiebe, Ian W. Gibson, Tom D. Blydt-Hansen, Peter W. Nickerson, Joana Sellarés, Marcos López-Hoyos, David San Segundo, María G. Crespo-Leiro, Raquel Marzoa-Rivas, Eduardo Barge-Caballero, María J. Paniagua-Martín, Antonio Román, Daniel Serón, Georg Böhmig, Elisabeth Schwaiger, Antibody-Mediated Rejection, Transplantation, 2014, 98, S3

    CrossRef

  2. 2
    Serdar Yilmaz, Chronic Allograft Nephropathy (Chronic Allograft Damage): Can It Be Avoided?, Current Transplantation Reports, 2014, 1, 2, 91

    CrossRef

  3. 3
    Annalisa Angelini, Chiara Castellani, Marny Fedrigo, Onno J. de Boer, Lorine B. Meijer-Jorna, Xiaofei Li, Marialuisa Valente, Gaetano Thiene, Allard C. van der Wal, Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification, Virchows Archiv, 2014, 464, 6, 627

    CrossRef

  4. 4
    Frank Lehner, Klemens Budde, Martin Zeier, Rudolf P. Wüthrich, Petra Reinke, Ute Eisenberger, Anja Mühlfeld, Wolfgang Arns, Rolf Stahl, Katharina Heller, Oliver Witzke, Heiner H. Wolters, Barbara Suwelack, Hans Ulrich Klehr, Manfred Stangl, Ingeborg A. Hauser, Silvio Nadalin, Martina Porstner, Christoph May, Eva-Maria Paulus, Claudia Sommerer, Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study, Transplant International, 2014, 27, 11
  5. 5
    Julie Ho, Chris Wiebe, Ian W. Gibson, Sabine Hombach-Klonisch, Ang Gao, Claudio Rigatto, Martin Karpinski, Leroy Storsley, Peter W. Nickerson, David N. Rush, Elevated Urinary CCL2, Transplantation, 2014, 98, 1, 39

    CrossRef

  6. 6
    Hatem Amer, Matthew D Griffin, Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?, Kidney International, 2014, 85, 2, 240

    CrossRef

  7. 7
    Clément Gosset, Carmen Lefaucheur, Denis Glotz, New insights in antibody-mediated rejection, Current Opinion in Nephrology and Hypertension, 2014, 23, 6, 597

    CrossRef

  8. 8
    S. Coelho, F. Ortíz, R. Gelpi, P. Koskinen, N. Porta, O. Bestard, E. Melilli, O. Taco, J. Torras, E. Honkanen, J. M. Grinyó, J. M. Cruzado, Sterile Leukocyturia Is Associated With Interstitial Fibrosis and Tubular Atrophy in Kidney Allograft Protocol Biopsies, American Journal of Transplantation, 2014, 14, 4
  9. 9
    Megan L. Troxell, Donald C. Houghton, The Basics of Renal Allograft Pathology, Surgical Pathology Clinics, 2014, 7, 3, 367

    CrossRef

  10. 10
    Irina B. Torres, Francesc Moreso, Eduard Sarró, Anna Meseguer, Daniel Serón, The Interplay between Inflammation and Fibrosis in Kidney Transplantation, BioMed Research International, 2014, 2014, 1

    CrossRef

  11. You have free access to this content11
    Tatsu Tanabe, The value of long-term protocol biopsies after kidney transplantation, Nephrology, 2014, 19,
  12. 12
    Naim Issa, Aleksandra Kukla, Hassan N. Ibrahim, Calcineurin Inhibitor Nephrotoxicity: A Review and Perspective of the Evidence, American Journal of Nephrology, 2013, 37, 6, 602

    CrossRef

  13. 13
    M. Naesens, D. R. J. Kuypers, K. De Vusser, Y. Vanrenterghem, P. Evenepoel, K. Claes, B. Bammens, B. Meijers, E. Lerut, Chronic Histological Damage in Early Indication Biopsies Is an Independent Risk Factor for Late Renal Allograft Failure, American Journal of Transplantation, 2013, 13, 1
  14. 14
    Ben Caplin, Kristin Veighey, Arundathi Mahenderan, Miriam Manook, Joanne Henry, Dorothea Nitsch, Mark Harber, Peter Dupont, David C. Wheeler, Gareth Jones, Bimbi Fernando, Alexander J. Howie, Peter Veitch, Early changes in scores of chronic damage on transplant kidney protocol biopsies reflect donor characteristics, but not future graft function, Clinical Transplantation, 2013, 27, 6
  15. 15
    N. Grenier, J.-L. Gennisson, F. Cornelis, Y. Le Bras, L. Couzi, Élastographie rénale par ultrasons, Journal de Radiologie Diagnostique et Interventionnelle, 2013, 94, 5, 560

    CrossRef

  16. 16
    D. Chhabra, A. Alvarado, P. Dalal, J. Leventhal, C. Wang, N. Sustento-Reodica, N. Najafian, A. Skaro, J. Levitsky, V. Mas, L. Gallon, Impact of Calcineurin-Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone-Free Regimen, American Journal of Transplantation, 2013, 13, 11
  17. 17
    Julie Ho, Chris Wiebe, David N. Rush, Claudio Rigatto, Leroy Storsley, Martin Karpinski, Ang Gao, Ian W. Gibson, Peter W. Nickerson, Increased Urinary CCL2, Transplantation Journal, 2013, 95, 4, 595

    CrossRef

  18. 18
    O. Franzese, A. Mascali, A. Capria, V. Castagnola, L. Paganizza, N. Di Daniele, Regulatory T Cells in the Immunodiagnosis and Outcome of Kidney Allograft Rejection, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  19. 19
    N. Grenier, J.-L. Gennisson, F. Cornelis, Y. Le Bras, L. Couzi, Renal ultrasound elastography, Diagnostic and Interventional Imaging, 2013, 94, 5, 545

    CrossRef

  20. 20
    David Rush, The impact of calcineurin inhibitors on graft survival, Transplantation Reviews, 2013, 27, 3, 93

    CrossRef

  21. 21
    Nicolas Grenier, Jean-Luc Gennisson, François Cornelis, Yann Le Bras, Lionel Couzi, Ultrasound Elastography of the Kidney, Ultrasound Clinics, 2013, 8, 4, 551

    CrossRef

  22. 22
    Verena Bröcker, Victoria Schubert, Irina Scheffner, Anke Schwarz, Marcus Hiss, Jan Ulrich Becker, Ralph Scherer, Hermann Haller, Hans Heinrich Kreipe, Michael Mengel, Wilfried Gwinner, Arteriolar Lesions in Renal Transplant Biopsies, The American Journal of Pathology, 2012, 180, 5, 1852

    CrossRef

  23. You have free access to this content23
    M. Mengel, B. Sis, M. Haas, R. B. Colvin, P. F. Halloran, L. C. Racusen, K. Solez, L. Cendales, A. J. Demetris, C. B. Drachenberg, C. F. Farver, E. R. Rodriguez, W. D. Wallace, D. Glotz, Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection, American Journal of Transplantation, 2012, 12, 3
  24. 24
    Swati Arora, Bhargavi Tangirala, Liliana Osadchuk, Kalathil K Sureshkumar, Belatacept : a new biological agent for maintenance immunosuppression in kidney transplantation, Expert Opinion on Biological Therapy, 2012, 12, 7, 965

    CrossRef

  25. 25
    Henrik Ekberg, Martin E. Johansson, Challenges and considerations in diagnosing the kidney disease in deteriorating graft function, Transplant International, 2012, 25, 11
  26. 26
    Walter D. Park, Timothy S. Larson, Matthew D. Griffin, Mark D. Stegall, Identification and Characterization of Kidney Transplants With Good Glomerular Filtration Rate at 1 Year But Subsequent Progressive Loss of Renal Function, Transplantation Journal, 2012, 94, 9, 931

    CrossRef

  27. 27
    Julie Ho, Chris Wiebe, Ian W. Gibson, David N. Rush, Peter W. Nickerson, Immune Monitoring of Kidney Allografts, American Journal of Kidney Diseases, 2012, 60, 4, 629

    CrossRef

  28. 28
    T. Yokoyama, O. Konno, Y. Nakamura, Y. Kihara, Y. Jojima, K. Hama, H. Iwamoto, M. Shimazu, M. Otani, Interstitial Fibrosis and Tubular Atrophy on Protocol Biopsies at 1 Year After Renal Transplantation, Transplantation Proceedings, 2012, 44, 3, 607

    CrossRef

  29. 29
    M. Gago, L. D. Cornell, W. K. Kremers, M. D. Stegall, F. G. Cosio, Kidney Allograft Inflammation and Fibrosis, Causes and Consequences, American Journal of Transplantation, 2012, 12, 5
  30. 30
    Mark Haas, Pathologic features of antibody-mediated rejection in renal allografts, Current Opinion in Nephrology and Hypertension, 2012, 21, 3, 264

    CrossRef

  31. 31
    Nicolas Grenier, Séverine Poulain, Sébastien Lepreux, Jean-Luc Gennisson, Benjamin Dallaudière, Yann Lebras, Eric Bavu, Aude Servais, Vannary Meas-Yedid, Mathieu Piccoli, Thomas Bachelet, Mickaël Tanter, Pierre Merville, Lionel Couzi, Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study, European Radiology, 2012, 22, 10, 2138

    CrossRef

  32. 32
    M. Naesens, O. Salvatierra, M. Benfield, R. B. Ettenger, V. Dharnidharka, W. Harmon, R. Mathias, M. M. Sarwal, Subclinical Inflammation and Chronic Renal Allograft Injury in a Randomized Trial on Steroid Avoidance in Pediatric Kidney Transplantation, American Journal of Transplantation, 2012, 12, 10
  33. 33
    Patricia E. Birk, Surveillance biopsies in children post-kidney transplant, Pediatric Nephrology, 2012, 27, 5, 753

    CrossRef

  34. 34
    Krista L. Lentine, Adrian Gheorghian, David Axelrod, Anu Kalsekar, Gilbert L’italien, Mark A. Schnitzler, The Implications of Acute Rejection for Allograft Survival in Contemporary U.S. Kidney Transplantation, Transplantation Journal, 2012, 94, 4, 369

    CrossRef

  35. 35
    Naim Issa, Aleksandra Kukla, Hassan N. Ibrahim, The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors, Arab Journal of Urology, 2012, 10, 2, 169

    CrossRef

  36. 36
    Mark D. Stegall, Marcio F. Chedid, Lynn D. Cornell, The role of complement in antibody-mediated rejection in kidney transplantation, Nature Reviews Nephrology, 2012, 8, 11, 670

    CrossRef

  37. You have free access to this content37
    Mark D. Stegall, Walter Park, Fernando Cosio, An Important Debate, American Journal of Transplantation, 2011, 11, 8
  38. 38
    JR Chapman, Chronic Calcineurin Inhibitor Use Is Nephrotoxic, Clinical Pharmacology & Therapeutics, 2011, 90, 2
  39. You have free access to this content39
    A. Loupy, D. Vernerey, G.S. Hill, Ch. Legendre, D. Anglicheau, Delineating the Picture of Renal Graft Injury in 2011, American Journal of Transplantation, 2011, 11, 8
  40. You have free access to this content40
    M. Mengel, M. Mihatsch, P. F. Halloran, Histological Characteristics of Calcineurin Inhibitor Toxicity—There Is No Such Thing as Specificity!, American Journal of Transplantation, 2011, 11, 12
  41. 41
    Ben Sprangers, Dirk R. Kuypers, Yves Vanrenterghem, Immunosuppression: Does One Regimen Fit All?, Transplantation, 2011, 92, 3, 251

    CrossRef

  42. 42
    M. D. Stegall, W. D. Park, P. G. Dean, F. G. Cosio, Improving Long-Term Renal Allograft Survival via a Road Less Traveled By, American Journal of Transplantation, 2011, 11, 7
  43. You have free access to this content43
    Sophie Brouard, Karine Renaudin, Jean-Paul Soulillou, Revisiting the Natural History of IF/TA in Renal Transplantation, American Journal of Transplantation, 2011, 11, 4
  44. 44
    R. Snanoudj, V. Royal, C. Elie, M. Rabant, C. Girardin, E. Morelon, H. Kreis, J.-C. Fournet, L.-H. Noël, C. Legendre, Specificity of Histological Markers of Long-Term CNI Nephrotoxicity in Kidney-Transplant Recipients Under Low-Dose Cyclosporine Therapy, American Journal of Transplantation, 2011, 11, 12
  45. 45
    L. K. Henderson, B. J. Nankivell, J. R. Chapman*, Surveillance Protocol Kidney Transplant Biopsies: Their Evolving Role in Clinical Practice, American Journal of Transplantation, 2011, 11, 8
  46. 46
    Mark D. Stegall, Patrick G. Dean, Rescue Immunosuppressive Therapy,